82 FR 58608 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 238 (December 13, 2017)

[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)]
[Notices]
[Pages 58608-58609]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-26780]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-1054]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Drug Overdose Response Investigation (DORI) 
Data Collections to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
July, 17, 2017 to obtain comments from the public and affected 
agencies. CDC received 10 comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Drug Overdose Response Investigation (DORI) Data Collections (OMB 
Control Number 0920-1054, Expiration 03/31/2018)--Extension--National 
Center for Injury Prevention and Control (NCIPC), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    In 2015, CDC received a three-year OMB approval (OMB Control Number 
0920-1054) for a new generic clearance plan to collect information in 
response to urgent requests from state and local health authorities to 
provide epidemiological information that allows for the selection of 
interventions to curb local epidemics of drug overdose. CDC seeks OMB 
approval for an extension of this generic clearance plan for another 
three-year period.
    Drug Overdose Response Investigation (DORI) are to be conducted in 
response to urgent requests from state and local health authorities to 
provide

[[Page 58609]]

epidemiological information that allows for the selection of 
interventions to curb local epidemics of drug overdose. Of particular 
interest is response to increasing trends in, or changing 
characteristics of, overdose from prescription drugs (with a special 
interest in opioid analgesics such as oxycodone or methadone; 
benzodiazepines such as alprazolam) and/or illicit drugs (e.g., 
heroin). CDC's National Center for Injury Prevention and Control 
(NCIPC) is frequently called upon to conduct DORIs at the request of 
state or local health authorities seeking support to respond to urgent 
public health problems resulting from drug use, misuse, addiction, and 
overdose. Such requests are typically, but not always, made through the 
Epi-Aid mechanism; in most investigations, CDC's epidemiological 
response entails rapid and flexible collection of data that evolves 
during the investigation period.
    CDC requests this plan to ensure that timely information is 
collected during a DORI, which allows NCIPC to maintain critical 
mission function by working with state and local health authorities to 
protect the public's health. During an unanticipated rise in nonfatal 
or fatal drug overdose where the substances responsible for the health 
event need to be identified, drivers and risk factors are undetermined, 
and/or subgroups at risk need to be identified, immediate action by CDC 
is necessary to minimize or prevent public harm. CDC must have the 
ability to rapidly deploy data collection tools to understand the scope 
of the problem and determine appropriate action. Procedures for each 
investigation, including specific data collection plans, depend on the 
time and resources available, number of persons involved, and other 
circumstances unique to the urgent conditions at hand. Data are 
collected by epidemiologists, psychologists, medical professionals, 
subject matter experts, and biostatisticians.
    Data collected during a DORI are used to understand sudden 
increases in drug use and misuse associated with fatal and nonfatal 
overdoses, understand the drivers and risk factors associated with 
those trends, and identify the groups most affected. This allows CDC to 
effectively advise states on actions that could be taken to control the 
local epidemic.
    During a DORI, data are collected once, with the rare need for 
follow-up. The estimated annual burden hours are 1,000, there is no 
increase in the burden hours from the previously approved collection. 
There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation    DORI Data Collection               2,000               1           30/60
 Participants.                           Instruments.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-26780 Filed 12-12-17; 8:45 am]
 BILLING CODE 4163-18-P